Although the relationship between MSI-H gastric carcinoma and PD-L1 status has not been fully explored, we hypothesized that a therapeutic strategy targeting the PD-1/PD-L1 interactions may be more effective in patients with MSI-H gastric carcinoma than in those with MSS gastric carcinoma. This evidence concerns the gene CD274 and gastric carcinoma.